According to ImmunoPrecise Antibodies's latest financial reports the company's current earnings are โน17.17 Million. In 2024 the company made an earning of -โน3.09 Billion a decrease over its 2023 earnings that were of -โน0.99 Billion. The earnings displayed on this page is the company's Pretax Income.